InspireMD to host a conference call at 4:30 p.m. ET on Wednesday, November 12th to review its financial results and business outlook.
U.S. Dial-in: (877) 407-0784
International Dial-in: (201) 689-8560
Recently Released Results of CGuard™ CARENET Trial on September 24th
Click Link below
U.S. Dial-in: (877) 407-0789
International Dial-in: (201) 689-8562
InspireMD Ltd. is a high growth medical device company focusing on the development and commercialization of its proprietary stent platform technology: MGuard™.
InspireMD has created a unique, patent-pending mesh net technology that wraps a stent, providing embolic protection (preventing Major Adverse Cardiac Events (MACE) by filtering debris) and reducing vessel injury by spreading strut pressure. MGuard™ is delivered with no change to the current procedure and is well-accepted by physicians. MGuard™ has been implanted in thousands of patients, and in clinical trials it has shown a more than 50% reduction in MACE compared with traditional bare metal stents.